nodes	percent_of_prediction	percent_of_DWPC	metapath
Lapatinib—EGFR—cervical cancer	0.633	1	CbGaD
Lapatinib—ABCB1—Topotecan—cervical cancer	0.0593	0.625	CbGbCtD
Lapatinib—CYP3A4—Topotecan—cervical cancer	0.0355	0.375	CbGbCtD
Lapatinib—Metastatic neoplasm—Topotecan—cervical cancer	0.0126	0.191	CcSEcCtD
Lapatinib—ERBB2—exocrine gland—cervical cancer	0.00589	0.0564	CbGeAlD
Lapatinib—Mucosal inflammation—Topotecan—cervical cancer	0.00438	0.0663	CcSEcCtD
Lapatinib—TAP1—uterine cervix—cervical cancer	0.00348	0.0333	CbGeAlD
Lapatinib—Interstitial lung disease—Topotecan—cervical cancer	0.00342	0.0519	CcSEcCtD
Lapatinib—TAP1—decidua—cervical cancer	0.00331	0.0318	CbGeAlD
Lapatinib—PIK3C2B—uterine cervix—cervical cancer	0.00327	0.0313	CbGeAlD
Lapatinib—TAP1—endometrium—cervical cancer	0.00315	0.0302	CbGeAlD
Lapatinib—PIK3C2B—decidua—cervical cancer	0.00311	0.0298	CbGeAlD
Lapatinib—TAP1—mammalian vulva—cervical cancer	0.00304	0.0292	CbGeAlD
Lapatinib—PIK3C2B—endometrium—cervical cancer	0.00295	0.0283	CbGeAlD
Lapatinib—PIK3C2B—mammalian vulva—cervical cancer	0.00286	0.0274	CbGeAlD
Lapatinib—Hyperbilirubinaemia—Topotecan—cervical cancer	0.00266	0.0404	CcSEcCtD
Lapatinib—Gefitinib—EGFR—cervical cancer	0.00258	1	CrCbGaD
Lapatinib—Blood bilirubin increased—Topotecan—cervical cancer	0.00256	0.0388	CcSEcCtD
Lapatinib—ERBB2—epithelium—cervical cancer	0.00256	0.0245	CbGeAlD
Lapatinib—ERBB4—epithelium—cervical cancer	0.00256	0.0245	CbGeAlD
Lapatinib—PIK3C2B—female reproductive system—cervical cancer	0.00245	0.0235	CbGeAlD
Lapatinib—ERBB2—decidua—cervical cancer	0.00242	0.0232	CbGeAlD
Lapatinib—PI4KB—uterine cervix—cervical cancer	0.00238	0.0228	CbGeAlD
Lapatinib—ERBB2—renal system—cervical cancer	0.00238	0.0228	CbGeAlD
Lapatinib—TAP1—female gonad—cervical cancer	0.00237	0.0227	CbGeAlD
Lapatinib—TAP1—vagina—cervical cancer	0.00236	0.0226	CbGeAlD
Lapatinib—ERBB2—endometrium—cervical cancer	0.0023	0.022	CbGeAlD
Lapatinib—PI4KB—decidua—cervical cancer	0.00227	0.0217	CbGeAlD
Lapatinib—PIK3C2B—female gonad—cervical cancer	0.00223	0.0213	CbGeAlD
Lapatinib—PI4KB—renal system—cervical cancer	0.00223	0.0213	CbGeAlD
Lapatinib—PIK3C2B—vagina—cervical cancer	0.00221	0.0212	CbGeAlD
Lapatinib—EGFR—uterine cervix—cervical cancer	0.00215	0.0206	CbGeAlD
Lapatinib—PI4KB—endometrium—cervical cancer	0.00215	0.0206	CbGeAlD
Lapatinib—ERBB2—uterus—cervical cancer	0.00212	0.0203	CbGeAlD
Lapatinib—PI4KB—mammalian vulva—cervical cancer	0.00208	0.0199	CbGeAlD
Lapatinib—PI4KB—uterus—cervical cancer	0.00198	0.019	CbGeAlD
Lapatinib—ERBB2—female reproductive system—cervical cancer	0.0019	0.0182	CbGeAlD
Lapatinib—ERBB4—female reproductive system—cervical cancer	0.0019	0.0182	CbGeAlD
Lapatinib—EGFR—mammalian vulva—cervical cancer	0.00188	0.0181	CbGeAlD
Lapatinib—EGFR—uterus—cervical cancer	0.00179	0.0172	CbGeAlD
Lapatinib—PI4KB—female reproductive system—cervical cancer	0.00178	0.0171	CbGeAlD
Lapatinib—ERBB2—female gonad—cervical cancer	0.00173	0.0166	CbGeAlD
Lapatinib—ERBB4—vagina—cervical cancer	0.00172	0.0165	CbGeAlD
Lapatinib—PI4KB—female gonad—cervical cancer	0.00162	0.0155	CbGeAlD
Lapatinib—PI4KB—vagina—cervical cancer	0.00161	0.0154	CbGeAlD
Lapatinib—Alanine aminotransferase increased—Topotecan—cervical cancer	0.00155	0.0235	CcSEcCtD
Lapatinib—TAP1—lymph node—cervical cancer	0.00152	0.0146	CbGeAlD
Lapatinib—EGFR—female gonad—cervical cancer	0.00147	0.0141	CbGeAlD
Lapatinib—PIK3C2B—lymph node—cervical cancer	0.00143	0.0137	CbGeAlD
Lapatinib—Neutropenia—Topotecan—cervical cancer	0.00142	0.0215	CcSEcCtD
Lapatinib—Pneumonia—Topotecan—cervical cancer	0.00136	0.0207	CcSEcCtD
Lapatinib—Infestation—Topotecan—cervical cancer	0.00136	0.0205	CcSEcCtD
Lapatinib—Infestation NOS—Topotecan—cervical cancer	0.00136	0.0205	CcSEcCtD
Lapatinib—Neuropathy peripheral—Topotecan—cervical cancer	0.00133	0.0201	CcSEcCtD
Lapatinib—Stomatitis—Topotecan—cervical cancer	0.00132	0.02	CcSEcCtD
Lapatinib—Hepatobiliary disease—Topotecan—cervical cancer	0.00128	0.0194	CcSEcCtD
Lapatinib—Epistaxis—Topotecan—cervical cancer	0.00128	0.0194	CcSEcCtD
Lapatinib—ERBB2—lymph node—cervical cancer	0.00111	0.0107	CbGeAlD
Lapatinib—Angiopathy—Topotecan—cervical cancer	0.0011	0.0167	CcSEcCtD
Lapatinib—Immune system disorder—Topotecan—cervical cancer	0.0011	0.0166	CcSEcCtD
Lapatinib—Mediastinal disorder—Topotecan—cervical cancer	0.0011	0.0166	CcSEcCtD
Lapatinib—Alopecia—Topotecan—cervical cancer	0.00108	0.0163	CcSEcCtD
Lapatinib—Malnutrition—Topotecan—cervical cancer	0.00106	0.016	CcSEcCtD
Lapatinib—PI4KB—lymph node—cervical cancer	0.00104	0.00999	CbGeAlD
Lapatinib—Back pain—Topotecan—cervical cancer	0.00102	0.0155	CcSEcCtD
Lapatinib—Anaemia—Topotecan—cervical cancer	0.000979	0.0148	CcSEcCtD
Lapatinib—Leukopenia—Topotecan—cervical cancer	0.000948	0.0144	CcSEcCtD
Lapatinib—EGFR—lymph node—cervical cancer	0.000944	0.00904	CbGeAlD
Lapatinib—Cough—Topotecan—cervical cancer	0.000924	0.014	CcSEcCtD
Lapatinib—Arthralgia—Topotecan—cervical cancer	0.000902	0.0137	CcSEcCtD
Lapatinib—Myalgia—Topotecan—cervical cancer	0.000902	0.0137	CcSEcCtD
Lapatinib—Unspecified disorder of skin and subcutaneous tissue—Topotecan—cervical cancer	0.000896	0.0136	CcSEcCtD
Lapatinib—Anaphylactic shock—Topotecan—cervical cancer	0.000865	0.0131	CcSEcCtD
Lapatinib—Infection—Topotecan—cervical cancer	0.000859	0.013	CcSEcCtD
Lapatinib—Nervous system disorder—Topotecan—cervical cancer	0.000848	0.0128	CcSEcCtD
Lapatinib—Skin disorder—Topotecan—cervical cancer	0.00084	0.0127	CcSEcCtD
Lapatinib—Anorexia—Topotecan—cervical cancer	0.000824	0.0125	CcSEcCtD
Lapatinib—Musculoskeletal discomfort—Topotecan—cervical cancer	0.000788	0.0119	CcSEcCtD
Lapatinib—Dyspnoea—Topotecan—cervical cancer	0.000771	0.0117	CcSEcCtD
Lapatinib—Dyspepsia—Topotecan—cervical cancer	0.000761	0.0115	CcSEcCtD
Lapatinib—Decreased appetite—Topotecan—cervical cancer	0.000752	0.0114	CcSEcCtD
Lapatinib—Gastrointestinal disorder—Topotecan—cervical cancer	0.000746	0.0113	CcSEcCtD
Lapatinib—Fatigue—Topotecan—cervical cancer	0.000745	0.0113	CcSEcCtD
Lapatinib—Constipation—Topotecan—cervical cancer	0.000739	0.0112	CcSEcCtD
Lapatinib—Gastrointestinal pain—Topotecan—cervical cancer	0.000707	0.0107	CcSEcCtD
Lapatinib—Abdominal pain—Topotecan—cervical cancer	0.000683	0.0104	CcSEcCtD
Lapatinib—CYP2C8—renal system—cervical cancer	0.000646	0.00619	CbGeAlD
Lapatinib—Hypersensitivity—Topotecan—cervical cancer	0.000637	0.00965	CcSEcCtD
Lapatinib—CYP2C8—endometrium—cervical cancer	0.000624	0.00598	CbGeAlD
Lapatinib—CYP3A5—uterine cervix—cervical cancer	0.000623	0.00597	CbGeAlD
Lapatinib—Asthenia—Topotecan—cervical cancer	0.00062	0.0094	CcSEcCtD
Lapatinib—Pruritus—Topotecan—cervical cancer	0.000612	0.00927	CcSEcCtD
Lapatinib—Diarrhoea—Topotecan—cervical cancer	0.000592	0.00896	CcSEcCtD
Lapatinib—CYP3A5—renal system—cervical cancer	0.000583	0.00559	CbGeAlD
Lapatinib—Vomiting—Topotecan—cervical cancer	0.00055	0.00833	CcSEcCtD
Lapatinib—Rash—Topotecan—cervical cancer	0.000545	0.00826	CcSEcCtD
Lapatinib—Dermatitis—Topotecan—cervical cancer	0.000545	0.00825	CcSEcCtD
Lapatinib—Headache—Topotecan—cervical cancer	0.000542	0.0082	CcSEcCtD
Lapatinib—CYP2C19—vagina—cervical cancer	0.000536	0.00514	CbGeAlD
Lapatinib—CYP2C8—female reproductive system—cervical cancer	0.000517	0.00496	CbGeAlD
Lapatinib—Nausea—Topotecan—cervical cancer	0.000514	0.00778	CcSEcCtD
Lapatinib—CYP2C8—vagina—cervical cancer	0.000468	0.00448	CbGeAlD
Lapatinib—CYP3A4—renal system—cervical cancer	0.000437	0.00419	CbGeAlD
Lapatinib—CYP3A5—female gonad—cervical cancer	0.000425	0.00407	CbGeAlD
Lapatinib—CYP3A5—vagina—cervical cancer	0.000422	0.00405	CbGeAlD
Lapatinib—CYP3A4—female reproductive system—cervical cancer	0.00035	0.00336	CbGeAlD
Lapatinib—ABCB1—epithelium—cervical cancer	0.000334	0.0032	CbGeAlD
Lapatinib—ABCB1—uterine cervix—cervical cancer	0.000331	0.00317	CbGeAlD
Lapatinib—ABCB1—decidua—cervical cancer	0.000315	0.00302	CbGeAlD
Lapatinib—ABCB1—renal system—cervical cancer	0.00031	0.00297	CbGeAlD
Lapatinib—ABCB1—endometrium—cervical cancer	0.000299	0.00287	CbGeAlD
Lapatinib—ABCB1—mammalian vulva—cervical cancer	0.000289	0.00277	CbGeAlD
Lapatinib—ABCB1—uterus—cervical cancer	0.000276	0.00264	CbGeAlD
Lapatinib—ABCB1—female reproductive system—cervical cancer	0.000248	0.00238	CbGeAlD
Lapatinib—ABCB1—female gonad—cervical cancer	0.000226	0.00216	CbGeAlD
Lapatinib—ABCB1—vagina—cervical cancer	0.000224	0.00215	CbGeAlD
Lapatinib—ABCB1—lymph node—cervical cancer	0.000145	0.00139	CbGeAlD
Lapatinib—EGFR—DAP12 interactions—FGFR3—cervical cancer	0.0001	0.00101	CbGpPWpGaD
Lapatinib—ERBB2—Signaling by PDGF—EGFR—cervical cancer	0.0001	0.00101	CbGpPWpGaD
Lapatinib—ERBB4—Signaling by EGFR—EGFR—cervical cancer	9.99e-05	0.001	CbGpPWpGaD
Lapatinib—ERBB2—NGF signalling via TRKA from the plasma membrane—STAT3—cervical cancer	9.98e-05	0.001	CbGpPWpGaD
Lapatinib—ERBB4—Adaptive Immune System—HLA-DQB1—cervical cancer	9.97e-05	0.001	CbGpPWpGaD
Lapatinib—ERBB2—Signaling by NGF—MTOR—cervical cancer	9.93e-05	0.000998	CbGpPWpGaD
Lapatinib—EGFR—Signaling by EGFR—FGFR3—cervical cancer	9.92e-05	0.000998	CbGpPWpGaD
Lapatinib—ERBB4—Signaling by EGFR in Cancer—EGFR—cervical cancer	9.9e-05	0.000996	CbGpPWpGaD
Lapatinib—ERBB4—Signaling by PDGF—EGFR—cervical cancer	9.86e-05	0.000992	CbGpPWpGaD
Lapatinib—EGFR—Signaling by EGFR in Cancer—FGFR3—cervical cancer	9.84e-05	0.000989	CbGpPWpGaD
Lapatinib—ERBB4—NGF signalling via TRKA from the plasma membrane—STAT3—cervical cancer	9.83e-05	0.000988	CbGpPWpGaD
Lapatinib—EGFR—Signaling by PDGF—FGFR3—cervical cancer	9.79e-05	0.000985	CbGpPWpGaD
Lapatinib—ERBB4—Signaling by NGF—MTOR—cervical cancer	9.78e-05	0.000983	CbGpPWpGaD
Lapatinib—PIK3C2B—Metabolism—MTHFR—cervical cancer	9.73e-05	0.000978	CbGpPWpGaD
Lapatinib—EGFR—Integrated Breast Cancer Pathway—CASP8—cervical cancer	9.72e-05	0.000978	CbGpPWpGaD
Lapatinib—ERBB2—Focal Adhesion—EGFR—cervical cancer	9.67e-05	0.000973	CbGpPWpGaD
Lapatinib—ERBB2—Integrated Pancreatic Cancer Pathway—EGFR—cervical cancer	9.63e-05	0.000968	CbGpPWpGaD
Lapatinib—ERBB2—B Cell Activation—EGFR—cervical cancer	9.47e-05	0.000953	CbGpPWpGaD
Lapatinib—ERBB2—Adaptive Immune System—CD8A—cervical cancer	9.45e-05	0.00095	CbGpPWpGaD
Lapatinib—EGFR—Androgen receptor signaling pathway—STAT3—cervical cancer	9.44e-05	0.000949	CbGpPWpGaD
Lapatinib—PI4KB—Metabolism—MTHFR—cervical cancer	9.4e-05	0.000945	CbGpPWpGaD
Lapatinib—ERBB2—Disease—WNT5A—cervical cancer	9.35e-05	0.000941	CbGpPWpGaD
Lapatinib—ERBB4—B Cell Activation—EGFR—cervical cancer	9.33e-05	0.000938	CbGpPWpGaD
Lapatinib—ERBB4—Adaptive Immune System—CD8A—cervical cancer	9.31e-05	0.000936	CbGpPWpGaD
Lapatinib—EGFR—B Cell Activation—FGFR3—cervical cancer	9.27e-05	0.000932	CbGpPWpGaD
Lapatinib—ERBB4—Disease—WNT5A—cervical cancer	9.21e-05	0.000926	CbGpPWpGaD
Lapatinib—ERBB2—Signaling by NGF—CASP3—cervical cancer	9.13e-05	0.000918	CbGpPWpGaD
Lapatinib—ERBB2—NGF signalling via TRKA from the plasma membrane—EGFR—cervical cancer	9.07e-05	0.000912	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—TAAR6—cervical cancer	9.06e-05	0.000911	CbGpPWpGaD
Lapatinib—EGFR—Rac1/Pak1/p38/MMP-2 pathway—TP53—cervical cancer	9.04e-05	0.000909	CbGpPWpGaD
Lapatinib—ERBB4—Signaling by NGF—CASP3—cervical cancer	8.99e-05	0.000904	CbGpPWpGaD
Lapatinib—EGFR—Spinal Cord Injury—CASP3—cervical cancer	8.96e-05	0.000901	CbGpPWpGaD
Lapatinib—ERBB4—NGF signalling via TRKA from the plasma membrane—EGFR—cervical cancer	8.93e-05	0.000898	CbGpPWpGaD
Lapatinib—EGFR—MAPK Signaling Pathway—CASP8—cervical cancer	8.93e-05	0.000898	CbGpPWpGaD
Lapatinib—EGFR—NGF signalling via TRKA from the plasma membrane—FGFR3—cervical cancer	8.87e-05	0.000892	CbGpPWpGaD
Lapatinib—TAP1—Immune System—MTOR—cervical cancer	8.78e-05	0.000883	CbGpPWpGaD
Lapatinib—TAP1—Immune System—CD4—cervical cancer	8.76e-05	0.000881	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—WNT2—cervical cancer	8.64e-05	0.000869	CbGpPWpGaD
Lapatinib—ERBB2—Developmental Biology—NOTCH1—cervical cancer	8.56e-05	0.00086	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—WNT2—cervical cancer	8.51e-05	0.000856	CbGpPWpGaD
Lapatinib—EGFR—Signaling by SCF-KIT—MTOR—cervical cancer	8.45e-05	0.00085	CbGpPWpGaD
Lapatinib—EGFR—ErbB1 downstream signaling—STAT3—cervical cancer	8.27e-05	0.000831	CbGpPWpGaD
Lapatinib—ABCB1—Allograft Rejection—CASP8—cervical cancer	8.24e-05	0.000829	CbGpPWpGaD
Lapatinib—ERBB2—Integrated Pancreatic Cancer Pathway—TP53—cervical cancer	8.09e-05	0.000813	CbGpPWpGaD
Lapatinib—EGFR—Downstream signaling of activated FGFR—MTOR—cervical cancer	8.09e-05	0.000813	CbGpPWpGaD
Lapatinib—EGFR—Integrated Pancreatic Cancer Pathway—CASP8—cervical cancer	8.06e-05	0.00081	CbGpPWpGaD
Lapatinib—ERBB2—Innate Immune System—FGFR3—cervical cancer	8.05e-05	0.000809	CbGpPWpGaD
Lapatinib—EGFR—Integrated Breast Cancer Pathway—MTOR—cervical cancer	8e-05	0.000804	CbGpPWpGaD
Lapatinib—EGFR—Signaling by ERBB4—MTOR—cervical cancer	7.96e-05	0.0008	CbGpPWpGaD
Lapatinib—ERBB4—Innate Immune System—FGFR3—cervical cancer	7.93e-05	0.000797	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—HLA-DPB1—cervical cancer	7.86e-05	0.000791	CbGpPWpGaD
Lapatinib—TAP1—Immune System—CTNNB1—cervical cancer	7.78e-05	0.000783	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—HLA-DPB1—cervical cancer	7.74e-05	0.000779	CbGpPWpGaD
Lapatinib—ERBB2—Adaptive Immune System—FGFR3—cervical cancer	7.73e-05	0.000777	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways in Glioblastoma—TP53—cervical cancer	7.69e-05	0.000773	CbGpPWpGaD
Lapatinib—ERBB2—Signaling by NGF—STAT3—cervical cancer	7.67e-05	0.000771	CbGpPWpGaD
Lapatinib—ERBB4—Adaptive Immune System—FGFR3—cervical cancer	7.61e-05	0.000766	CbGpPWpGaD
Lapatinib—EGFR—Downstream signal transduction—MTOR—cervical cancer	7.6e-05	0.000764	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—AKAP13—cervical cancer	7.59e-05	0.000763	CbGpPWpGaD
Lapatinib—EGFR—Signaling by FGFR—MTOR—cervical cancer	7.56e-05	0.00076	CbGpPWpGaD
Lapatinib—EGFR—EGF/EGFR Signaling Pathway—MTOR—cervical cancer	7.56e-05	0.00076	CbGpPWpGaD
Lapatinib—ERBB4—Signaling by NGF—STAT3—cervical cancer	7.56e-05	0.00076	CbGpPWpGaD
Lapatinib—EGFR—Signaling by ERBB2—MTOR—cervical cancer	7.53e-05	0.000757	CbGpPWpGaD
Lapatinib—EGFR—DAP12 signaling—MTOR—cervical cancer	7.49e-05	0.000753	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—AKAP13—cervical cancer	7.47e-05	0.000752	CbGpPWpGaD
Lapatinib—EGFR—Downstream signaling events of B Cell Receptor (BCR)—MTOR—cervical cancer	7.38e-05	0.000742	CbGpPWpGaD
Lapatinib—EGFR—Integrated Breast Cancer Pathway—CASP3—cervical cancer	7.36e-05	0.00074	CbGpPWpGaD
Lapatinib—EGFR—Integrated Breast Cancer Pathway—CTNNB1—cervical cancer	7.09e-05	0.000713	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—WNT2—cervical cancer	7.07e-05	0.000711	CbGpPWpGaD
Lapatinib—EGFR—DAP12 interactions—MTOR—cervical cancer	7.05e-05	0.000708	CbGpPWpGaD
Lapatinib—EGFR—Signaling by FGFR in disease—MTOR—cervical cancer	7.05e-05	0.000708	CbGpPWpGaD
Lapatinib—EGFR—Fc epsilon receptor (FCERI) signaling—MTOR—cervical cancer	7.05e-05	0.000708	CbGpPWpGaD
Lapatinib—EGFR—Signaling by EGFR—MTOR—cervical cancer	6.98e-05	0.000702	CbGpPWpGaD
Lapatinib—ERBB2—Signaling by NGF—EGFR—cervical cancer	6.97e-05	0.000701	CbGpPWpGaD
Lapatinib—EGFR—Signaling by EGFR in Cancer—MTOR—cervical cancer	6.92e-05	0.000696	CbGpPWpGaD
Lapatinib—EGFR—Signaling by PDGF—MTOR—cervical cancer	6.89e-05	0.000693	CbGpPWpGaD
Lapatinib—ERBB2—Innate Immune System—CASP8—cervical cancer	6.88e-05	0.000692	CbGpPWpGaD
Lapatinib—ERBB4—Signaling by NGF—EGFR—cervical cancer	6.87e-05	0.000691	CbGpPWpGaD
Lapatinib—EGFR—Signaling by NGF—FGFR3—cervical cancer	6.82e-05	0.000686	CbGpPWpGaD
Lapatinib—TAP1—Immune System—STAT3—cervical cancer	6.78e-05	0.000682	CbGpPWpGaD
Lapatinib—ERBB4—Innate Immune System—CASP8—cervical cancer	6.78e-05	0.000682	CbGpPWpGaD
Lapatinib—EGFR—MAPK Signaling Pathway—CASP3—cervical cancer	6.76e-05	0.000679	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—WNT5A—cervical cancer	6.55e-05	0.000659	CbGpPWpGaD
Lapatinib—EGFR—Signaling by SCF-KIT—STAT3—cervical cancer	6.53e-05	0.000657	CbGpPWpGaD
Lapatinib—EGFR—B Cell Activation—MTOR—cervical cancer	6.52e-05	0.000656	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—WNT5A—cervical cancer	6.45e-05	0.000649	CbGpPWpGaD
Lapatinib—EGFR—Immune System—UBE3A—cervical cancer	6.37e-05	0.00064	CbGpPWpGaD
Lapatinib—ERBB2—Axon guidance—EGFR—cervical cancer	6.31e-05	0.000635	CbGpPWpGaD
Lapatinib—EGFR—Adaptive Immune System—HLA-DPB1—cervical cancer	6.27e-05	0.00063	CbGpPWpGaD
Lapatinib—EGFR—NGF signalling via TRKA from the plasma membrane—MTOR—cervical cancer	6.24e-05	0.000627	CbGpPWpGaD
Lapatinib—ABCB1—Allograft Rejection—CASP3—cervical cancer	6.24e-05	0.000627	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—AKAP13—cervical cancer	6.21e-05	0.000624	CbGpPWpGaD
Lapatinib—TAP1—Immune System—EGFR—cervical cancer	6.17e-05	0.00062	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—HLA-DQB1—cervical cancer	6.14e-05	0.000617	CbGpPWpGaD
Lapatinib—EGFR—Integrated Pancreatic Cancer Pathway—CASP3—cervical cancer	6.1e-05	0.000613	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—HLA-DQB1—cervical cancer	6.05e-05	0.000608	CbGpPWpGaD
Lapatinib—EGFR—Disease—WNT2—cervical cancer	5.97e-05	0.0006	CbGpPWpGaD
Lapatinib—EGFR—Focal Adhesion—CTNNB1—cervical cancer	5.9e-05	0.000593	CbGpPWpGaD
Lapatinib—EGFR—Integrated Pancreatic Cancer Pathway—CTNNB1—cervical cancer	5.88e-05	0.000591	CbGpPWpGaD
Lapatinib—EGFR—Downstream signal transduction—STAT3—cervical cancer	5.87e-05	0.000591	CbGpPWpGaD
Lapatinib—EGFR—EGF/EGFR Signaling Pathway—STAT3—cervical cancer	5.84e-05	0.000588	CbGpPWpGaD
Lapatinib—EGFR—Spinal Cord Injury—TP53—cervical cancer	5.75e-05	0.000578	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—CD8A—cervical cancer	5.73e-05	0.000576	CbGpPWpGaD
Lapatinib—ERBB2—Developmental Biology—CTNNB1—cervical cancer	5.68e-05	0.000572	CbGpPWpGaD
Lapatinib—ERBB2—Innate Immune System—MTOR—cervical cancer	5.66e-05	0.000569	CbGpPWpGaD
Lapatinib—ERBB2—Innate Immune System—CD4—cervical cancer	5.65e-05	0.000568	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—CD8A—cervical cancer	5.65e-05	0.000568	CbGpPWpGaD
Lapatinib—ERBB4—Innate Immune System—MTOR—cervical cancer	5.58e-05	0.000561	CbGpPWpGaD
Lapatinib—ERBB4—Innate Immune System—CD4—cervical cancer	5.57e-05	0.00056	CbGpPWpGaD
Lapatinib—EGFR—Developmental Biology—HES1—cervical cancer	5.48e-05	0.000551	CbGpPWpGaD
Lapatinib—EGFR—Signaling by FGFR in disease—STAT3—cervical cancer	5.44e-05	0.000548	CbGpPWpGaD
Lapatinib—ERBB2—Adaptive Immune System—MTOR—cervical cancer	5.44e-05	0.000547	CbGpPWpGaD
Lapatinib—ERBB2—Adaptive Immune System—CD4—cervical cancer	5.43e-05	0.000546	CbGpPWpGaD
Lapatinib—ERBB2—Disease—HES1—cervical cancer	5.38e-05	0.000541	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—WNT5A—cervical cancer	5.36e-05	0.000539	CbGpPWpGaD
Lapatinib—ERBB4—Adaptive Immune System—MTOR—cervical cancer	5.36e-05	0.000539	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—TAAR6—cervical cancer	5.35e-05	0.000538	CbGpPWpGaD
Lapatinib—ERBB4—Adaptive Immune System—CD4—cervical cancer	5.35e-05	0.000538	CbGpPWpGaD
Lapatinib—EGFR—Signaling by PDGF—STAT3—cervical cancer	5.32e-05	0.000535	CbGpPWpGaD
Lapatinib—ERBB4—Disease—HES1—cervical cancer	5.3e-05	0.000533	CbGpPWpGaD
Lapatinib—ERBB2—Innate Immune System—CTNNB1—cervical cancer	5.02e-05	0.000505	CbGpPWpGaD
Lapatinib—EGFR—Direct p53 effectors—TP53—cervical cancer	5.01e-05	0.000504	CbGpPWpGaD
Lapatinib—ERBB2—Developmental Biology—STAT3—cervical cancer	4.95e-05	0.000498	CbGpPWpGaD
Lapatinib—ERBB4—Innate Immune System—CTNNB1—cervical cancer	4.94e-05	0.000497	CbGpPWpGaD
Lapatinib—EGFR—Adaptive Immune System—HLA-DQB1—cervical cancer	4.89e-05	0.000492	CbGpPWpGaD
Lapatinib—EGFR—NGF signalling via TRKA from the plasma membrane—STAT3—cervical cancer	4.82e-05	0.000485	CbGpPWpGaD
Lapatinib—EGFR—Signaling by NGF—MTOR—cervical cancer	4.8e-05	0.000483	CbGpPWpGaD
Lapatinib—ERBB2—Disease—MTHFR—cervical cancer	4.73e-05	0.000476	CbGpPWpGaD
Lapatinib—EGFR—Integrated Breast Cancer Pathway—TP53—cervical cancer	4.72e-05	0.000474	CbGpPWpGaD
Lapatinib—ERBB2—Disease—TERT—cervical cancer	4.72e-05	0.000474	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—FGFR3—cervical cancer	4.69e-05	0.000471	CbGpPWpGaD
Lapatinib—ERBB4—Disease—MTHFR—cervical cancer	4.66e-05	0.000468	CbGpPWpGaD
Lapatinib—ERBB4—Disease—TERT—cervical cancer	4.65e-05	0.000467	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—FGFR3—cervical cancer	4.62e-05	0.000464	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—NOTCH2—cervical cancer	4.6e-05	0.000462	CbGpPWpGaD
Lapatinib—EGFR—Adaptive Immune System—CD8A—cervical cancer	4.57e-05	0.000459	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—NOTCH2—cervical cancer	4.53e-05	0.000455	CbGpPWpGaD
Lapatinib—EGFR—Disease—WNT5A—cervical cancer	4.52e-05	0.000455	CbGpPWpGaD
Lapatinib—ERBB2—Developmental Biology—EGFR—cervical cancer	4.5e-05	0.000453	CbGpPWpGaD
Lapatinib—EGFR—Signaling by NGF—CASP3—cervical cancer	4.41e-05	0.000444	CbGpPWpGaD
Lapatinib—EGFR—MAPK Signaling Pathway—TP53—cervical cancer	4.33e-05	0.000436	CbGpPWpGaD
Lapatinib—ERBB2—Disease—FGFR3—cervical cancer	4.33e-05	0.000435	CbGpPWpGaD
Lapatinib—ERBB4—Disease—FGFR3—cervical cancer	4.26e-05	0.000429	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—WNT2—cervical cancer	4.18e-05	0.00042	CbGpPWpGaD
Lapatinib—EGFR—Developmental Biology—NOTCH1—cervical cancer	4.14e-05	0.000416	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—cervical cancer	4.07e-05	0.000409	CbGpPWpGaD
Lapatinib—ERBB2—Disease—NOTCH1—cervical cancer	4.06e-05	0.000409	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—CASP8—cervical cancer	4.01e-05	0.000403	CbGpPWpGaD
Lapatinib—ERBB4—Disease—NOTCH1—cervical cancer	4e-05	0.000402	CbGpPWpGaD
Lapatinib—ERBB2—Innate Immune System—EGFR—cervical cancer	3.98e-05	0.0004	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—CASP8—cervical cancer	3.95e-05	0.000397	CbGpPWpGaD
Lapatinib—ERBB4—Innate Immune System—EGFR—cervical cancer	3.92e-05	0.000394	CbGpPWpGaD
Lapatinib—EGFR—Integrated Pancreatic Cancer Pathway—TP53—cervical cancer	3.91e-05	0.000393	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—FGFR3—cervical cancer	3.89e-05	0.000391	CbGpPWpGaD
Lapatinib—ERBB2—Adaptive Immune System—EGFR—cervical cancer	3.82e-05	0.000384	CbGpPWpGaD
Lapatinib—EGFR—Immune System—HLA-DPB1—cervical cancer	3.8e-05	0.000382	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—HES1—cervical cancer	3.77e-05	0.000379	CbGpPWpGaD
Lapatinib—ERBB4—Adaptive Immune System—EGFR—cervical cancer	3.76e-05	0.000378	CbGpPWpGaD
Lapatinib—EGFR—Adaptive Immune System—FGFR3—cervical cancer	3.74e-05	0.000376	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—HES1—cervical cancer	3.71e-05	0.000373	CbGpPWpGaD
Lapatinib—EGFR—Signaling by NGF—STAT3—cervical cancer	3.71e-05	0.000373	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—AKAP13—cervical cancer	3.67e-05	0.000369	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—CASP8—cervical cancer	3.33e-05	0.000335	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—TERT—cervical cancer	3.3e-05	0.000332	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—MTOR—cervical cancer	3.3e-05	0.000332	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—CD4—cervical cancer	3.29e-05	0.000331	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—TERT—cervical cancer	3.25e-05	0.000327	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—MTOR—cervical cancer	3.25e-05	0.000327	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—CD4—cervical cancer	3.24e-05	0.000326	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—WNT5A—cervical cancer	3.17e-05	0.000318	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—CA9—cervical cancer	3.16e-05	0.000317	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—cervical cancer	3.08e-05	0.000309	CbGpPWpGaD
Lapatinib—ERBB2—Disease—MTOR—cervical cancer	3.04e-05	0.000306	CbGpPWpGaD
Lapatinib—ERBB2—Disease—CD4—cervical cancer	3.04e-05	0.000306	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—FGFR3—cervical cancer	3.03e-05	0.000305	CbGpPWpGaD
Lapatinib—ERBB4—Disease—MTOR—cervical cancer	3e-05	0.000302	CbGpPWpGaD
Lapatinib—ERBB4—Disease—CD4—cervical cancer	2.99e-05	0.000301	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—FGFR3—cervical cancer	2.99e-05	0.0003	CbGpPWpGaD
Lapatinib—EGFR—Immune System—HLA-DQB1—cervical cancer	2.97e-05	0.000298	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—cervical cancer	2.97e-05	0.000298	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—CTNNB1—cervical cancer	2.92e-05	0.000294	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—CTNNB1—cervical cancer	2.88e-05	0.00029	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—NOTCH1—cervical cancer	2.85e-05	0.000286	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—NOTCH1—cervical cancer	2.8e-05	0.000282	CbGpPWpGaD
Lapatinib—EGFR—Immune System—CD8A—cervical cancer	2.77e-05	0.000279	CbGpPWpGaD
Lapatinib—EGFR—Developmental Biology—CTNNB1—cervical cancer	2.75e-05	0.000276	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—MTOR—cervical cancer	2.74e-05	0.000275	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—CA9—cervical cancer	2.73e-05	0.000275	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—CD4—cervical cancer	2.73e-05	0.000275	CbGpPWpGaD
Lapatinib—ERBB2—Disease—CTNNB1—cervical cancer	2.7e-05	0.000271	CbGpPWpGaD
Lapatinib—ERBB4—Disease—CTNNB1—cervical cancer	2.66e-05	0.000267	CbGpPWpGaD
Lapatinib—EGFR—Adaptive Immune System—MTOR—cervical cancer	2.63e-05	0.000264	CbGpPWpGaD
Lapatinib—EGFR—Adaptive Immune System—CD4—cervical cancer	2.62e-05	0.000264	CbGpPWpGaD
Lapatinib—EGFR—Disease—HES1—cervical cancer	2.6e-05	0.000262	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—STAT3—cervical cancer	2.55e-05	0.000256	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—STAT3—cervical cancer	2.51e-05	0.000252	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—CA9—cervical cancer	2.44e-05	0.000245	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—CTNNB1—cervical cancer	2.43e-05	0.000244	CbGpPWpGaD
Lapatinib—EGFR—Developmental Biology—STAT3—cervical cancer	2.4e-05	0.000241	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—CA9—cervical cancer	2.38e-05	0.00024	CbGpPWpGaD
Lapatinib—ERBB2—Disease—STAT3—cervical cancer	2.35e-05	0.000237	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—cervical cancer	2.35e-05	0.000236	CbGpPWpGaD
Lapatinib—ERBB4—Disease—STAT3—cervical cancer	2.32e-05	0.000233	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—EGFR—cervical cancer	2.32e-05	0.000233	CbGpPWpGaD
Lapatinib—EGFR—Disease—MTHFR—cervical cancer	2.29e-05	0.00023	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—EGFR—cervical cancer	2.28e-05	0.000229	CbGpPWpGaD
Lapatinib—EGFR—Disease—TERT—cervical cancer	2.28e-05	0.000229	CbGpPWpGaD
Lapatinib—EGFR—Immune System—FGFR3—cervical cancer	2.27e-05	0.000228	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—NOTCH2—cervical cancer	2.22e-05	0.000223	CbGpPWpGaD
Lapatinib—ERBB2—Disease—EGFR—cervical cancer	2.14e-05	0.000215	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—MTOR—cervical cancer	2.13e-05	0.000214	CbGpPWpGaD
Lapatinib—ERBB4—Disease—EGFR—cervical cancer	2.11e-05	0.000212	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—MTOR—cervical cancer	2.1e-05	0.000211	CbGpPWpGaD
Lapatinib—EGFR—Disease—FGFR3—cervical cancer	2.09e-05	0.00021	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—cervical cancer	1.97e-05	0.000198	CbGpPWpGaD
Lapatinib—EGFR—Disease—NOTCH1—cervical cancer	1.96e-05	0.000198	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—CASP3—cervical cancer	1.96e-05	0.000197	CbGpPWpGaD
Lapatinib—EGFR—Immune System—CASP8—cervical cancer	1.94e-05	0.000195	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—CASP3—cervical cancer	1.93e-05	0.000194	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—CTNNB1—cervical cancer	1.89e-05	0.00019	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—CTNNB1—cervical cancer	1.86e-05	0.000187	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—HES1—cervical cancer	1.82e-05	0.000183	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—STAT3—cervical cancer	1.65e-05	0.000166	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—STAT3—cervical cancer	1.62e-05	0.000163	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—TERT—cervical cancer	1.6e-05	0.000161	CbGpPWpGaD
Lapatinib—EGFR—Immune System—MTOR—cervical cancer	1.59e-05	0.00016	CbGpPWpGaD
Lapatinib—EGFR—Immune System—CD4—cervical cancer	1.59e-05	0.00016	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—EGFR—cervical cancer	1.5e-05	0.000151	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—EGFR—cervical cancer	1.48e-05	0.000148	CbGpPWpGaD
Lapatinib—EGFR—Disease—MTOR—cervical cancer	1.47e-05	0.000148	CbGpPWpGaD
Lapatinib—EGFR—Disease—CD4—cervical cancer	1.47e-05	0.000148	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—CA9—cervical cancer	1.47e-05	0.000148	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—FGFR3—cervical cancer	1.47e-05	0.000147	CbGpPWpGaD
Lapatinib—EGFR—Immune System—CTNNB1—cervical cancer	1.41e-05	0.000142	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—NOTCH1—cervical cancer	1.38e-05	0.000138	CbGpPWpGaD
Lapatinib—EGFR—Disease—CTNNB1—cervical cancer	1.31e-05	0.000131	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—MTHFR—cervical cancer	1.28e-05	0.000129	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—TP53—cervical cancer	1.26e-05	0.000126	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—TP53—cervical cancer	1.24e-05	0.000125	CbGpPWpGaD
Lapatinib—EGFR—Immune System—STAT3—cervical cancer	1.23e-05	0.000124	CbGpPWpGaD
Lapatinib—EGFR—Disease—STAT3—cervical cancer	1.14e-05	0.000114	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—MTHFR—cervical cancer	1.11e-05	0.000112	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—MTOR—cervical cancer	1.03e-05	0.000104	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—MTHFR—cervical cancer	9.9e-06	9.96e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—MTHFR—cervical cancer	9.67e-06	9.72e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—CASP3—cervical cancer	9.48e-06	9.53e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—CTNNB1—cervical cancer	9.14e-06	9.19e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—STAT3—cervical cancer	7.97e-06	8.01e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—TP53—cervical cancer	6.08e-06	6.11e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—MTHFR—cervical cancer	5.95e-06	5.99e-05	CbGpPWpGaD
